Bradley L. Radoff - 14 Apr 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role
Director
Signature
/s/ Radoff Bradley Louis
Issuer symbol
ENZB
Transactions as of
14 Apr 2022
Net transactions value
+$87,300
Form type
4
Filing time
15 Apr 2022, 10:23:02 UTC
Previous filing
17 Mar 2022
Next filing
29 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENZ Common Stock, $0.01 Par Value Award $87,300 +30,000 +7.5% $2.91 430,000 14 Apr 2022 By The Radoff Family Foundation F1, F2
holding ENZ Common Stock, $0.01 Par Value 3,898,100 14 Apr 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock are directly held by The Radoff Family Foundation (the "Radoff Foundation"). Mr. Radoff is a director of the Radoff Foundation and may be deemed to beneficially own the shares of Common Stock held by the Radoff Foundation. Mr. Radoff disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F2 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transaction prices ranging from $2.91 to $2.9155 inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.